BD Alaris Infusion Pump Class Action Suit Settled for $85 Million

BD has announced a settlement in the class action lawsuit related to its Alaris infusion pumps, agreeing to pay $85 million to resolve all the claims against the company and it officers.

The Alaris infusion pumps were subject to an FDA Class I recall in 2020 which involved hardware and software issues including stuck keypads, low battery alarm failure and several programming errors for the 774,000 units sold in the U.S.

The BD Alaris device is used to deliver medications, fluids and blood products through a single integrated platform that includes large volume pumps, syringe pumps and patient-controlled analgesia modules for adult, pediatric and neonatal patients. The company received 510(k) clearance for both remediation of existing units and sale of new units in July 2023.

To read the whole story, click here to subscribe.

Related Topics